Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA revises labels for ED drugs

FDA said it approved labeling changes for erectile dysfunction (ED) drugs in the class that includes Cialis tadalafil, Levitra vardenafil

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE